Skip to main content

Table 3 GI tools by guideline condition, country and organization

From: Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines

Guideline characteristic (n guidelines) One or more GI tools (n, % of guidelines) GI tools (n,% of total GI tools) GI tools per guideline with one or more GI tools
Yes No Mean Median Min Max
Condition
 Heart failure (37) 19 (51.5) 18 (48.6) 88 (19.0) 4.6 4.0 1.0 11.0
 Diabetes (29) 20 (69.0) 9 (31.0) 130 (28.0) 6.5 4.0 1.0 25.0
 Stroke (21) 17 (81.0) 4 (19.0) 100 (21.6) 5.9 4.0 1.0 26.0
 Arthritis (15) 12 (80.0) 3 (20.0) 35 (7.5) 2.9 3.0 1.0 7.0
 Asthma (8) 8 (100.0) 0 (0.0) 50 (10.8) 6.3 4.0 1.0 28.0
 Colorectal cancer (8) 3 (37.5) 5 (62.5) 19 (4.1) 6.3 1.0 1.0 17.0
 Depression (8) 6 (75.0) 2 (25.0) 42 (9.1) 7.0 7.5 1.0 13.0
Country
 United States (76) 44 (57.9) 32 (42.1) 199 (42.9) 4.5 2.5 1.0 28.0
 United Kingdom (27) 26 (96.3) 1 (3.7) 151 (32.5) 5.8 4.5 3.0 17.0
 Canada (9) 7 (77.8) 2 (22.2) 90 (19.4) 12.9 8.0 2.0 26.0
 Australia (5) 4 (80.0) 1 (20.0) 11 (2.4) 2.8 1.0 1.0 8.0
 International group (3) 2 (66.7) 1 (33.3) 8 (1.7) 4.0 4.0 4.0 4.0
 Finland (3) 0 (0.0) 3 (100.0) 0 (0.0) 0.0 0.0 0.0 0.0
 Spain (1) 0 (0.0) 1 (100.0) 0 (0.0) 0.0 0.0 0.0 0.0
 Singapore (1) 1 (100.0) 0 (0.0) 3 (0.6) 3.0 3.0 3.0 3.0
 Brazil (1) 1 (100.0) 0 (0.0) 2 (0.4) 2.0 2.0 2.0 2.0
Organization
 Professional society (61) 38 (62.3) 23 (37.7) 135 (29.1) 3.6 2.0 1.0 25.0
 Government agency (28) 27 (96.4) 1 (3.6) 166 (35.8) 6.1 5.0 2.0 19.0
 Disease foundation (17) 5 (29.4) 12 (70.6) 63 (13.6) 12.6 9.0 1.0 26.0
 Non-profit agency (9) 7 (77.8) 2 (22.2) 33 (7.1) 4.7 2.0 1.0 15.0
 Academic institution (9) 7 (77.8) 2 (22.2) 66 (14.2) 9.4 7.0 1.0 28.0
 International group (2) 1 (50.0) 1 (50.0) 1 (0.2) 1.0 1.0 1.0 1.0
Overall (126) 85 (67.5) 41 (32.5) 464 (100.0) 5.5 4.0 1.0 28.0